Ultrasound and endocrinological markers of first trimester placentation and subsequent fetal size by David, AL & Jauniaux, E
                             Elsevier Editorial System(tm) for Placenta 
                                  Manuscript Draft 
 
 
Manuscript Number: PL-15-00058R3 
 
Title: Ultrasound And Endocrinological Markers Of First Trimester 
Placentation And Subsequent Fetal Size  
 
Article Type: Original Article 
 
Keywords: Placental volume; birth weight; placental hormones; large for 
gestational age; small for gestational age 
 
Corresponding Author: Dr. Anna Louise David, MB ChB, MRCOG, PhD 
 
Corresponding Author's Institution: University College London 
 
First Author: Anna Louise David, MB ChB, MRCOG, PhD 
 
Order of Authors: Anna Louise David, MB ChB, MRCOG, PhD; Eric R Jauniaux, 
PhD FRCOG 
 
Abstract: Introduction: To study the relationship between 2-dimensional 
placental ultrasound measurements and maternal serum (MS) levels of 
biomarkers of placentation and in pregnancies presenting with an isolated 
abnormally high or low birthweight at term, without evidence of placental 
insufficiency.  
Method:  We performed a population based cohort study of 306 pregnancies 
delivered at term including 30 presenting with large-for-gestational age 
(LGA, birthweight > 90th centile) and 17 small-for-gestational age (SGA; 
birthweight < 10th centile). Antenatal measurements included placental 
thickness and 2D-volume and MS levels of pregnancy-associated plasma 
protein A (PAPP-A) and free-beta human chorionic gonadotrophin (fβhCG) at 
11 - 13+6 weeks of gestation and mid-trimester MS α-fetoprotein (AFP), 
unconjugated estriol (uE3) and inhibin A levels. 
Results: In the subgroup with a normal birthweight (10th-90th centile), 
there was a significant positive correlation between birthweight and the 
basal plate surface area (p<0.001) and 2D placental volume (p< 0.01). In 
the LGA subgroup, MS PAPP-A was significantly (p<0.05) higher than in 
normal controls and there was a significant (p<0.01) positive correlation 
with birthweight. There was no significant difference for any of the 
ultrasound and biomarkers parameters between SGA and the normally grown 
controls. 
Discussion: In uncomplicated singleton pregnancies with a normal 
birthweight, 2D measurements of placentation are related with fetal size 
but are not related to subsequent excessive or slow fetal growth. LGA at 
birth is associated with increased MS PAPP-A at 11-14 weeks of gestation 
supporting the association between PAPP-A synthesis and early placental 
growth and development. 
 
 
 
 
 
Dear Graham 
 
As requested, I have added in the Supplementary Figures 1 and 2 (Scatter plot 
illustrating the relationship between first trimester placental surface area or 2D 
volume and birthweight for the whole cohort), 
Eric has added the statistical data for these results into the results section on 
page 10. He also corrected 2 typos and added 2 decimals in all the F numbers for 
consistency. 
 
Yours sincerely 
Anna David 
Response to Reviewers
Conflict of Interest Statement 
 
The authors state that no conflict of interest exists. 
*Conflict of Interest Statement
Click here to download Conflict of Interest Statement: Conflict of Interest Statement.docx
Ultrasound And Endocrinological Markers Of 
First Trimester Placentation And Subsequent 
Fetal Size 
  
A.L. DAVID, E. JAUNIAUX 
 
Research Department of Maternal Fetal Medicine, Institute for Women's 
Health, University College London, 86-96 Chenies Mews, London WC1E 
6HX, UK. 
 
 
 
 
Correspondence address: 
Dr Anna David, 
Research Department of Maternal Fetal Medicine,  
Institute for Women’s Health 
University College London,  
86-96 Chenies Mews, 
London WC1E 6HX, UK. 
Telephone numbers:  
+44/207/6796059  
Fax: +44/207/3837429 
a.david@ucl.ac.uk 
 
 
*Title Page and Abstract
ABSTRACT (243 words) 
Introduction: To study the relationship between 2-dimensional placental 
ultrasound measurements and maternal serum (MS) levels of biomarkers of 
placentation and in pregnancies presenting with an isolated abnormally high 
or low birthweight at term, without evidence of placental insufficiency.  
Method:  We performed a population based cohort study of 306 pregnancies 
delivered at term including 30 presenting with large-for-gestational age (LGA, 
birthweight > 90th centile) and 17 small-for-gestational age (SGA; birthweight 
< 10th centile). Antenatal measurements included placental thickness and 2D-
volume and MS levels of pregnancy-associated plasma protein A (PAPP-A) 
and free-beta human chorionic gonadotrophin (fhCG) at 11 - 13+6 weeks of 
gestation and mid-trimester MS α-fetoprotein (AFP), unconjugated estriol 
(uE3) and inhibin A levels. 
Results: In the subgroup with a normal birthweight (10th-90th centile), there 
was a significant positive correlation between birthweight and the basal plate 
surface area (p<0.001) and 2D placental volume (p< 0.01). In the LGA 
subgroup, MS PAPP-A was significantly (p<0.05) higher than in normal 
controls and there was a significant (p<0.01) positive correlation with 
birthweight. There was no significant difference for any of the ultrasound and 
biomarkers parameters between SGA and the normally grown controls. 
Discussion: In uncomplicated singleton pregnancies with a normal 
birthweight, 2D measurements of placentation are related with fetal size but 
are not related to subsequent excessive or slow fetal growth. LGA at birth is 
associated with increased MS PAPP-A at 11-14 weeks of gestation 
supporting the association between PAPP-A synthesis and early placental 
growth and development. 
Keywords: Placental volume, birth weight, placental hormones, large for 
gestational age, small for gestational age 
 
Highlights 
 In a population based cohort study of 306 uncomplicated singleton 
pregnancies delivered at term, 2D placental measurements correlate with 
fetal size in the total study group and To study the relationship between 2D 
placental measurements, maternal placental biomarkers and fetal growth 
complications 
 in uncomplicated singleton pregnancies with a normal birthweight 2D 
placental measurements correlate with fetal size 
 Placental basal plate surface area and 2D placental volume do not predict 
large or small fetal size and these measurements cannot be used to predict 
birthweight in individual cases.. 
 Large (LGA) and small for gestational age (SGA) at birth are not associated 
with 2D ultrasound measurements of the placenta 
 LGA but not SGA is associated with raised first trimester maternal serum 
pregnancy-associated plasma proteinFirst trimester maternal serum 
pregnancy-associated plasma protein concentration is higher in LGA 
pregnancies than compared with normal and AGA pregnancies.  
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ABSTRACT (243 words) 28 
Introduction: To study the relationship between 2-dimensional placental 29 
ultrasound measurements and maternal serum (MS) levels of biomarkers of 30 
placentation and in pregnancies presenting with an isolated abnormally high 31 
or low birthweight at term, without evidence of placental insufficiency.  32 
Method:  We performed a population based cohort study of 306 pregnancies 33 
delivered at term including 30 presenting with large-for-gestational age (LGA, 34 
birthweight > 90th centile) and 17 small-for-gestational age (SGA; birthweight 35 
< 10th centile). Antenatal measurements included placental thickness and 2D-36 
volume and MS levels of pregnancy-associated plasma protein A (PAPP-A) 37 
and free-beta human chorionic gonadotrophin (fhCG) at 11 - 13+6 weeks of 38 
gestation and mid-trimester MS α-fetoprotein (AFP), unconjugated estriol 39 
(uE3) and inhibin A levels. 40 
Results: In the subgroup with a normal birthweight (10th-90th centile), there 41 
was a significant positive correlation between birthweight and the basal plate 42 
surface area (p<0.001) and 2D placental volume (p< 0.01). In the LGA 43 
subgroup, MS PAPP-A was significantly (p<0.05) higher than in normal 44 
controls and there was a significant (p<0.01) positive correlation with 45 
birthweight. There was no significant difference for any of the ultrasound and 46 
biomarkers parameters between SGA and the normally grown controls. 47 
Discussion: In uncomplicated singleton pregnancies with a normal 48 
birthweight, 2D measurements of placentation are related with fetal size but 49 
are not related to subsequent excessive or slow fetal growth. LGA at birth is 50 
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associated with increased MS PAPP-A at 11-14 weeks of gestation 51 
supporting the association between PAPP-A synthesis and early placental 52 
growth and development. 53 
Keywords: Placental volume, birth weight, placental hormones, large for 54 
gestational age, small for gestational age 55 
56 
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1. Introduction 57 
Major changes take place in the uterine environment between the first 58 
trimester and the rest of pregnancy [1]. These changes are characterised by 59 
the establishment of the intervillous circulation, a switch from histiotrophic to 60 
haemotrophic fetal nutrition and the remodelling of the primitive placenta [2]. 61 
In early pregnancy, the oxygen concentration within the chorionic sac is 62 
maintained at a low value to protect the primitive placenta and the developing 63 
fetus from the teratogenic effect of oxygen free radicals [1,2]. The onset of the 64 
maternal arterial circulations at the end of the first trimester leads to a three-65 
fold rise in the intraplacental oxygen concentration [1,3]. The haemodynamics 66 
of the utero-placental circulation and distribution of oxygen around and inside 67 
the placenta play an important role in shaping the topography of the villous 68 
tree of the definitive placenta and the formation of the free placental 69 
membranes [1-3].  70 
Fetal size is dependent on nutrient availability, which in turn is related 71 
to villous development and the capacity of the villous trophoblast to transport 72 
these nutrients [4]. Sufficient dilation of the utero-placental circulation together 73 
with rapid villous angiogenesis are the key factors necessary for adequate 74 
placental development and function, and subsequent fetal growth. Placental 75 
and fetal development is related and placental growth kinetics are important 76 
features predicting post-natal health and in particular cardiovascular 77 
adaptations in childhood, even when fetal size is in the normal range [5]. At 78 
birth, there is a correlation between fetal and placental weight and the ratio of 79 
these weights i.e. the feto-placental weight ratio (FPR) gives retrospectively 80 
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an indication of the appropriateness of fetal growth during pregnancy and 81 
estimates the potential risks for chronic diseases in later life [6]. 82 
The placenta actively produces a large number of hormones that serve 83 
to regulate and balance maternal and fetal physiology and in particular fetal 84 
growth via the production and metabolism of growth-regulating hormones [7].  85 
The expression of numerous signaling molecules is altered in the placentas 86 
from pregnancies affected by the fetal growth complications of fetal growth 87 
restriction and macrosomia. Many maternal serum (MS) biomarkers have 88 
been proposed for the detection of abnormal fetal growth but when used 89 
alone in the first trimester they have a limited role as screening tests. For 90 
example, pregnancy-associated plasma protein-A (PAPP-A) during the first 91 
trimester cannot be used alone as a marker of excessive fetal growth, large  92 
[8] or of small-for-gestational age (SGA) [9,11]. Similarly new biomarkers such 93 
as adiponectin, a hormone that regulates glucose levels and fatty acid 94 
oxidation, have been recently tested in the first trimester to predict fetal size 95 
later in pregnancy with variable results [12,13]. 96 
For decades, ultrasound remains the best method for the screening 97 
diagnosis, characterization and follow-up of abnormal fetal growth. The 98 
advent of Doppler ultrasound has enabled the study of the development of the 99 
uterine and umbilical circulations in utero from early in normal pregnancy [14]. 100 
Further studies have shown an association between uterine circulation, 101 
abnormal placental features including size, abnormal level of biomarkers in 102 
MS and abnormal fetal growth [15,16]. More recently 3-dimensional (3D) 103 
ultrasound has enabled the study of placental volume in utero throughout 104 
pregnancy. These studies have shown an association between placental 105 
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volume at 11-13 weeks and birth weight in pregnancies with a normal and 106 
complicated outcome [17-22].  107 
The combination of the assessment of placental size and shape with 108 
3D ultrasound and MS biomarkers can serve as the foundation upon which to 109 
build a multivariate model for the early prediction of abnormal fetal size. The 110 
broad variability in placental volume 3D measurements and current time-111 
consuming approach compared to 2D ultrasound has made its clinical use 112 
difficult [23]. In this study, we investigated the relationship between first 113 
trimester (11 - 13+6 weeks of gestation) 2D ultrasound measurements of 114 
placentation and MS levels of commonly measured placental proteins PAPP-115 
A and free-beta human chorionic gonadotrophin (fhCG), and mid-trimester 116 
(15-22+0 weeks of gestation) inhibin and subsequent fetal size. 117 
 118 
2. Patients and methods  119 
A group of 476 women booked for antenatal care at University College 120 
London Hospital (UCLH) were recruited prospectively over a 40-month period. 121 
All pregnant women at UCLH are offered a screening test for Trisomy 21 122 
which combines nuchal translucency (NT) measurement and MS levels of 123 
PAPP-A and fhCG at 11–13+6 weeks (combined test) and/or of AFP, uE3 124 
and inhibin-A at 15–22+0 weeks (integrated test). All women were recruited at 125 
the time of the NT ultrasound examination between 11+0 and 13+6 weeks of 126 
gestation (77-97 gestational days) as determined either by menstrual age, or 127 
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when there was a discrepancy of more than 5 days by the ultrasound 128 
measurement of the fetal crown-rump length (CRL).  129 
 Demographic data including maternal age, ethnicity, parity, cigarette 130 
smoke exposure, age and body mass index (BMI) were collected from 131 
questionnaires completed at the time of the first appointment. All women 132 
underwent routine screening for gestational diabetes with a random glucose 133 
at booking and at 28 weeks of gestation. In addition women with specific risk 134 
factors (previous LGA, family history of diabetes) were offered a formal 2 hour 135 
glucose tolerance test at 28 weeks. Pregnancy outcome information was 136 
collected from the medical case notes and hospital electronic patient records. 137 
The birthweight percentile was calculated using the customized gestational 138 
age related optimal growth chart (GROW) (www.gestation.net), which takes 139 
into account ethnicity, maternal height, weight, age and fetal birthweight and 140 
gender.  141 
 Women diagnosed with a first trimester miscarriage, fetal abnormality, 142 
medical condition, multiple pregnancy and abnormal pregnancy outcome 143 
including, late miscarriage, intrauterine death, stillbirth, preterm (<37 weeks of 144 
gestation) or post-term delivery (≥41+6 weeks of gestation), smokers or lost to 145 
follow-up were excluded from the analysis.  Placental pathology results were 146 
available for cases of SGA and IUGR identified at birth. 147 
2.1 Ultrasound examination 148 
All examinations were performed using a 3.5-5 MHz ultrasound probe 149 
(Voluson 730 and E8 Expert, GE, USA). In all cases, the fetal NT, CRL and 150 
basic anatomy were obtained. The placental basal plate dimensions and 151 
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thickness were measured by viewing the whole placenta as previously 152 
described [25,26]. Three measurements of each parameter were taken and 153 
they were subsequently averaged for analysis. In brief the longest sagittal and 154 
transverse diameters of the placental basal plate were measured at the level 155 
of the utero-placental interface and the placental thickness was measured 156 
underneath the cord insertion. The basal plate surface area of the placenta 157 
was estimated using the following formula: Sagittal length x transverse length 158 
x π/4. The placental volume was calculated as being the equation for half the 159 
volume of an ellipsoid: ½ (sagittal length x transverse length x thickness x 160 
4/3π), as previously described [24]. The placental measurements were 161 
entered into the prospective study database at the time of the ultrasound 162 
scan. Four sonographers were trained by the study authors prior to the study 163 
commencement so as to perform the placental ultrasound measurements in a 164 
reproducible and systematic way. 165 
2.2 Bioassays 166 
MS PAPP-A and fhCG levels were measured using the AutoDELFIA PAPP-167 
A, time-resolved fluoro-immunoassay (PerkinElmer, Turku, Finland). Inhibin A 168 
MS levels were measured using a commercial ELISA. The measured proteins 169 
were converted to multiple of the median (MoM) for a pregnancy of the same 170 
gestational age and adjusted for maternal age and ethnicity.  171 
2.3 Study group and statistical analysis 172 
The study group included 306 non-smoking women with a spontaneous 173 
singleton pregnancy delivering after an uncomplicated pregnancy between 174 
37+1 weeks (259 days of pregnancy) and 41+6 weeks (286 days of pregnancy). 175 
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The study group was divided into 3 subgroups according to the neonatal 176 
weight percentile at birth adjusted for neonatal gender [24]. Cases in the 177 
large-for-gestatonal age (LGA, birth weight > 90th centile) and SGA (birth 178 
weight <10th centile with no evidence of fetal growth restriction, as defined as 179 
abnormal umbilical artery and uterine artery Doppler or abnormal 180 
cerebroplacental ratio) subgroup were individually matched for maternal BMI, 181 
parity and for the CRL with three cases from the normal (10-90th centile) 182 
subgroup. The study was approved by the Joint UCL/UCLH Committees on 183 
the Ethics of Human Research (Reference Number: 05/Q0505/82). All women 184 
received information about the study and written consent was obtained prior 185 
to the ultrasound examination.  186 
 The data were analyzed using the StatGraphic data analysis and 187 
statistical software package (Station, TX). Standard Kurtosis analysis 188 
indicated that some values were not normally distributed and are therefore 189 
presented as median and interquartile range (IQR). The median values of the 190 
different variable investigated in the macrosomic and SGA subgroups and 191 
controls were compared using a Mann-Whitney (Wilcoxon) W test. Individual 192 
correlations between the different ultrasound, endocrinologic and clinical 193 
variables were calculated by the least square method and their slopes tested 194 
for significance by the F ratio test.  A p value of <0.05 was considered 195 
significant. 196 
3. Results 197 
There were 259 (84.6%) pregnancies with a birthweight between 10th and 90th 198 
centile (normal), 30 (9.8%) with a birthweight >90th centile (LGA) and 17 199 
(5.6%) with a birthweight below the 10th centile (SGA).  200 
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The regression analysis between birthweight and the ultrasound and 201 
endocrinologic parameters in the entire study group indicated a significant 202 
positive correlation with placental basal surface area (F= 11.03; r=0.41: 203 
P<0.005) and 2D volume (F= 7.60; r=0.29, p<0.01), (Supplementary Figures 1 204 
and 2) and MS PAPP-A concentration (F= 5.10; r=0.14, p<0.05), but no such 205 
relationship existed for MS fhCG. 206 
3.1 Normal birth weight  207 
At the time of the ultrasound examination, the median CRL was 62.3 mm (IQR 208 
56.1;70). Using the NIH BMI calculator (www.nhlbi.nih.gov/ guidelines/obesity/ 209 
BMI/ bmicalc.htm), 12 women were classified at the antenatal booking 210 
appointment (8-10 weeks of gestation) as underweight (BMI < 18.5), 181 as 211 
normal weight (BMI 18.5-24.9), 52 as overweight (BMI 25-29.9 and 14 as 212 
obese (> 30).  213 
Table 1 displays and compares the clinical, ultrasound and 214 
endocrinological data of women with a BMI < 25 with those with a BMI > 25. 215 
The MS level of fhCG at 11-13+6 weeks was significantly (p<0.05) higher in 216 
women with a BMI > 25. There was no significant difference for the other 217 
parameters between the two subgroups.  218 
There was a significant positive correlation between the basal plate 219 
surface area (F= 10.30; r=0.20, p<0.001) and placental volume (F= 7.60; 220 
r=0.17, p< 0.01) at 11-13+6 weeks and subsequent fetal size. There was no 221 
significant correlation between MS fhCG or PAPP-A at 11-13+6 weeks and 222 
mid-trimester AFP, uE3 and inhibin MS levels and fetal size. 223 
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3.2 LGA 224 
The median birthweight was 4128g in the LGA subgroup (IQR 4000;4350) 225 
compared to 3289 g in the AGA subgroup (IQR 3121;3487, p<0.001). The 226 
concentration of MS PAPP-A at 11-13+6 weeks was significantly (p<0.05) 227 
higher in the serum of the women delivering an LGA neonate than in controls 228 
with a normal birthweight at term (Table 2). There was no significant 229 
difference for the ultrasound parameters in this subgroup. There was a 230 
significant positive correlation (F= 8.03; r=0.20, p<0.01) between MS PAPP-A 231 
concentration and increased birthweight at term (Figure 1), but no such 232 
relationship existed for MS fhCG AFP, uE3 and inhibin.  233 
3.4 SGA 234 
The median birthweight was 2850g in the SGA subgroup (IQR 2800;2922) 235 
compared to 3462 g in the AGA control subgroup (IQR 3206;3632, p<0.001). 236 
There was no significant difference for the ultrasound and endocrinologic 237 
parameters between SGA and control pregnancies (Table 3). There was no 238 
significant correlation between MS-hormonal levels at 11-13+6 weeks and mid-239 
trimester and SGA. 240 
241 
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4. Discussion 242 
Our results indicate a relationship between 2D measurements of the 243 
placentation area and volume, MS PAPP-A at 11-13+6 weeks of gestation and 244 
birthweight in uncomplicated singleton pregnancies that deliver at term. In 245 
otherwise uncomplicated pregnancies, presenting with LGA or SGA at term, 246 
2D first-trimester ultrasound measurements of placentation are not related to 247 
abnormal fetal size and only MS PAPP-A are related to subsequent excessive 248 
fetal size. 249 
There are well-documented associations between the levels of first and 250 
second trimester MS biomarkers and abnormal placental development in 251 
pregnancies subsequently complicated by pre-eclampsia and intrauterine 252 
growth restriction (IUGR). A longitudinal study has shown that in cases of 253 
IUGR, with or without accompanying pre-eclampsia, the placenta is already 254 
smaller at 12-18 weeks of gestation on ultrasound than in healthy controls 255 
[26]. In the most severe cases of deficient arterial conversion the intervillous 256 
circulation is abnormal from the beginning of the second trimester, resulting in 257 
pronounced ultrasonographic changes in placental texture [14,27,28], that are 258 
associated with IUGR, pre-eclampsia and high MS alpha-fetoprotein levels at 259 
18-28 weeks [14]. In these pregnancies, there is a narrow implantation basis 260 
or basal plate diameter, increased thickness and patchy decrease in placental 261 
echogenicity secondary to the fetal plate being pushed up by jet-like blood 262 
streams from the spiral arteries [14]. We have previously shown that in 263 
pregnancies subsequently complicated by pre-eclampsia, the levels of MS 264 
PAPP-A are lower at the end of the first trimester and the basal plate surface 265 
area is smaller [24] reflecting indirectly the development of the definitive 266 
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placenta [24,25].  These findings support the concept that placental-related 267 
complications of the second-half of gestation have their pathophysiological 268 
origin in abnormal placentation and utero-placental development during the 269 
first trimester of pregnancy [3].  270 
In the present study, we have excluded pregnancies with an existing or 271 
subsequent medical complications such as pre-eclampsia or gestational 272 
diabetes and those that delivered pre or post-term. We observed that in the 273 
subgroup presenting with a normal birthweight at term, there was a significant 274 
positive correlation between birthweight and the basal plate surface area 275 
(p<0.001) and PV (p< 0.01). In this subgroup, we also found that the MS level 276 
of hCG at 11-13+6 weeks was significantly higher (p<0.05) in women with a 277 
BMI > 25 than in women with a BMI < 25. First-trimester 3D placental volume 278 
is closely associated with fetal and placental size [18] and hCG synthesis is 279 
related to trophoblast proliferation and promotes development and growth of 280 
the spiral arteries [29]. These findings highlight the pivotal interaction between 281 
normal placentation, placental biosynthesis functions and normal fetal size, 282 
and confirms that maternal BMI is a confounding factor that needs to be 283 
adjusted for the first-trimester biochemical screening of trisomy 21. 284 
In the LGA subgroup, we found that the MS PAPP-A at 11-13+6 weeks 285 
of gestation was significantly higher (p<0.05) than in normal controls and was 286 
positively correlated with birthweight at term. PAPP-A is mainly produced by 287 
the villous trophoblast and during pregnancy its synthesis is up-regulated by 288 
progesterone, which promotes the adhesion and proliferation potential of 289 
trophoblastic cells [30]. It is also a key regulator of insulin-like growth factor 290 
bioavailability essential for normal fetal development. This can explain why at 291 
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11-13+6 weeks of gestation, low MS levels of PAPP-A have been associated 292 
with a higher risk of pre-eclampsia and poor fetal growth during the second 293 
half of pregnancy [8-11,25,31]. Conversely, high MS PAPP-A levels as in the 294 
present study have been associated with increased fetal size [21,32]. 295 
However, the sensitivity of MS PAPP-A at 11-13+6 weeks of gestation is too 296 
low to be solely used as a screening method for the prediction of abnormal 297 
birth weight and perinatal complications [8,9,11].  298 
We found no difference in the ultrasound and biomarker parameters in 299 
the present study between SGA and normal birthweight controls. It is possible 300 
that our small sample size in the SGA group could explain the lack of 301 
relationship between the parameters and fetal size in the SGA group. The 302 
conflicting results from studies using first and second trimester 3D placental 303 
volume measurements to predict fetal size in the third trimester [18,33] are 304 
probably because of the difficulties with manual placental segmentation. In the 305 
future innovative automatic segmentation approaches for 3D ultrasound may 306 
be find placental measurements to be clinically applicable [34]. Variation in 307 
placental volume is greater in the first trimester before 10 weeks i.e. before 308 
the definitive placenta is fully formed [35], with a fundal or low placental 309 
position being more difficult to assess than the fully anterior or posterior 310 
position [33]. We have previously found that in pregnancies with a normal 311 
outcome, there is no significant relationship between placental shape at 11-312 
13+6 weeks of gestation and birthweight or centile, suggesting that the 313 
placental shape is not completely determined during the early phases of 314 
placentation and is not directly related to fetal size during the first half of 315 
pregnancy [24,25].   316 
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A distinct relationship exists between the uterine spiral arteries and the 317 
fetal or placental lobules and the finding of a smaller basal plate surface area 318 
at 11-13+6 weeks of gestation in pregnancies subsequently complicated by 319 
pre-eclampsia [24]. This also suggests that ultrasound measurements of the 320 
basal surface area reflects placentation indirectly and that this parameter is 321 
less likely to be affected by the physiological morphological changes in the 322 
placental structure between 8 and 12 weeks of gestation than placental 323 
volume evaluated with 3D ultrasound.  324 
Conclusion 325 
In uncomplicated singleton pregnancies with a normal birthweight, 2D 326 
measurements of placentation are related with fetal size but are not related to 327 
subsequent excessive or slow fetal growth. LGA at birth is associated with 328 
increased MS PAPP-A at 11-14 weeks of gestation supporting the association 329 
between PAPP-A synthesis and early placental growth and development. The 330 
clinical use of routine first trimester placental measurements in uncomplicated 331 
pregnancies remains to be evaluated by large prospective cohorts. 332 
 333 
 334 
 335 
 336 
 337 
338 
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Table 1. Comparison (W test) of the birthweight, crown rump length (CRL), ultrasound 
and endocrinological data in women with a booking BMI < 25 (n= 193) with those with a 
BMI > 25 (n= 66). BMI was measured at 8-10 weeks of gestation 
Variables          BMI < 25   BMI >25     
     Median    LQ;UQ                 Median    LQ;UQ       p 
_______________________________________________________________________                                                                                                               
CRL (mm)     63       56;70      62        57;70  0.80 
Birthweight (g)   3475   3226;3689   3454    3251;3622  0.89 
Placental thickness (mm) 18.1    15.6;21.6    18.4     16.1;21.8       0.81 
Basal plate surface (mm2)  442    319;531     398      313;517            0.23 
Placental volume (mm3) 67.2    45.6;94.7    61.9      47.7;77.8  0.35 
fβhCG (MoM)   0.98    0.69;1.42    1.20     0.76;1.84         <0.05 
Inhibin A (MoM)  0.95    0.74;1.29    1.10     0.80;1.27           0.23 
PAPP-A (MoM)  1.08    0.74;1.51    0.95     0.70;1.30           0.19 
______________________________________________________________________ 
Data are presented as median and lower quartile (LQ); upper quartile (UQ). 
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Table 2. Comparison of the median for the ultrasound and endocrinological 
measurements of placental development in LGA neonates (birthweight >90th centile, n= 
30) and controls (birthweight 10th-90th centile, n=90). 
Variables              LGA    Controls      
     Median    LQ;UQ                 Median    LQ;UQ       p 
_______________________________________________________________________                                                                                                               
Placental thickness (mm) 18.2    15.2;21.7    17.9     15.3;22.0     0.91 
Basal plate surface (mm2)  446    366;522     453      346;556            0.36 
Placental volume (mm3) 63.4    47.7;87.1     68.4      49.9;87.5     0.71 
fβhCG (MoM)   1.13    0.69;1.59    1.09     0.72;1.46       0.78 
Inhibin A (MoM)  0.88    0.67;1.18    1.02     0.78;1.26      0.17 
PAPP-A (MoM)  1.27    0.98;1.73    1.03     0.74;1.46          <0.05 
______________________________________________________________________ 
Data are presented as median and lower quartile (LQ); upper quartile (UQ). 
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Table 3. Comparison of the median for the ultrasound and endocrinological 
measurements of placental development in SGA neonates (birthweight <10th centile, n= 
17) and controls (birthweight 10th-90th centile, n=56). 
Variables                   SGA        Controls      
     Median    LQ;UQ                 Median    LQ;UQ       p 
_______________________________________________________________________                                                                                                               
Placental thickness (mm) 17.5    14.7;19.3    18.5     17.5;21.5     0.11 
Basal plate surface (mm2)  458    368;586     443      318;519            0.91 
Placental volume (mm3) 64.5    52.7;82.4     67.6      47.1;88.6     0.27 
fβhCG (MoM)   1.09    0.91;1.58    1.11     0.75;1.58       0.87 
Inhibin A (MoM)  0.98    0.80;1.08    1.09     0.78;1.37      0.45 
PAPP-A (MoM)  1.15    0.91;1.26    1.08     0.74;1.49            0.91 
______________________________________________________________________ 
Data are presented as median and lower quartile (LQ); upper quartile (UQ). 
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Figure 1 Legend 483 
Scatter plot illustrating the relationship between first trimester maternal serum 484 
PAPP-A Multiple of the Median (MoM) and birthweight in the Large for 485 
Gestational Age group. The regression line is indicated in blue, the red and 486 
the purple lines indicate the confidence intervals.  487 
Supplementary Figure 1 Legend 488 
Scatter plot illustrating the relationship between first trimester placental 489 
surface area and birthweight for the whole cohort. The regression line is 490 
indicated in blue, the red and the purple lines indicate the confidence 491 
intervals.  492 
Supplementary Figure 2 Legend 493 
Scatter plot illustrating the relationship between first trimester placental 2D 494 
volume and birthweight for the whole cohort. The regression line is indicated 495 
in blue, the red and the purple lines indicate the confidence intervals.  496 
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Plot of Fitted Model
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